Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

Recent & Breaking News (TSXV:SBM)

Sirona Biochem (TSXV:SBM) to present ground-breaking anti-aging technology at BIO conference

Shoran Devi May 3, 2023

Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston

GlobeNewswire May 3, 2023

Sirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326

GlobeNewswire April 25, 2023

Sirona Biochem Announces Close of Oversubscribed Debenture Financing

GlobeNewswire April 20, 2023

Sirona Biochem Announces Debenture Financing

GlobeNewswire March 23, 2023

Sirona Biochem (TSXV:SBM) receives antiviral resting results

Brieanna McCutcheon  February 27, 2023

Sirona Biochem Receives Antiviral Testing Results

GlobeNewswire February 27, 2023

Sirona Biochem (TSXV:SBM) terminates supply agreement with Rodan + Fields

Brieanna McCutcheon  January 16, 2023

Sirona Biochem Announces the Termination of Supply Agreement with Rodan + Fields

GlobeNewswire January 16, 2023

Sirona Biochem Announces 2022 Annual Meeting Results

GlobeNewswire December 30, 2022

Sirona Biochem (TSXV:SBM) begins clinical trial for anti-aging compound TFC-1326

Azuka Onwuka December 8, 2022

Sirona Biochem Announces Start of Clinical Trial for Anti-Aging Compound TFC-1326

GlobeNewswire December 8, 2022

Sirona Biochem (TSXV:SBM) & Wanbang Biopharma sign international partnership agreement

Jonathon Brown November 23, 2022

Sirona Biochem Signs International Partnership Agreement with Wanbang Biopharmaceuticals

GlobeNewswire November 23, 2022

Sirona Biochem (TSXV:SBM) sees positive safety study results for anti-aging compound

Jonathon Brown November 16, 2022

Sirona Biochem Reports Positive Results in Safety Study for Anti-Aging Compound TFC-1326

GlobeNewswire November 16, 2022

Sirona Biochem (TSXV:SBM) announces research agreement with ICGEB

Trevor Abes  November 10, 2022

Sirona Biochem Signs Research Collaboration Agreement with International Centre for Genetic Engineering and Biotechnology

GlobeNewswire November 10, 2022

Sirona Biochem Issues Corporate Update

GlobeNewswire September 28, 2022

Sirona Biochem Corporate Update

GlobeNewswire July 12, 2022